Does TORSEMIDE Cause Left ventricular hypertrophy? 44 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Left ventricular hypertrophy have been filed in association with TORSEMIDE (Torsemide). This represents 0.5% of all adverse event reports for TORSEMIDE.
44
Reports of Left ventricular hypertrophy with TORSEMIDE
0.5%
of all TORSEMIDE reports
1
Deaths
44
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From TORSEMIDE?
Of the 44 reports, 1 (2.3%) resulted in death, 44 (100.0%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORSEMIDE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does TORSEMIDE Cause?
General physical health deterioration (1,233)
Dyspnoea (1,176)
Acute kidney injury (975)
Dizziness (870)
Oedema peripheral (823)
Fall (707)
Dehydration (705)
Cardiac failure (698)
Hypotension (689)
Fatigue (635)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which TORSEMIDE Alternatives Have Lower Left ventricular hypertrophy Risk?
TORSEMIDE vs TOVIAZ
TORSEMIDE vs TOVORAFENIB
TORSEMIDE vs TOZINAMERAN
TORSEMIDE vs TRABECTEDIN
TORSEMIDE vs TRACLEER